国药一致,Sinopharm Accord,
国药集团一致药业股份有限公司(简称国药一致)是集医药研发、制药工业、药品分销、医药物流为一体的综合性医药上市公司(A股000028,B股200028),是中国医药集团、国药控股在中国南区的核心企业,承担着国家、省、市政府药品特储任务。国药一致拥有工业和分销两大业态,属下企业共有32家,分布于广东、广西、江苏等地区。截至目前,企业销售规模超200亿元,拥有员工4100多人。
国药一致制药工业集产品研发、原料与制剂生产、市场营销于一体,产品主要覆盖抗感染、呼吸系统用药、消化系统用药、心脑血管用药以及中成药、保健品等领域。其全资企业深圳致君制药有限公司、国药控股深圳中药有限公司,苏州致君万庆药业有限公司,参股企业深圳万乐药业有限公司均为国家级高新技术企业,重点品种头孢呋辛、头孢克肟、头孢西丁、头孢米诺、头孢哌坦等原料或制剂在细分市场处于领先地位,并拥有7个单品销售超亿元。其中,深圳致君制药有限公司是国内首家自主产品注册通过欧盟GMP认证的头孢粉针制剂生产厂商,位列中国制药工业企业50强。
国药一致药品分销业务位居广东、广西榜首,名列中国医药商业20强,下属企业29家,分布于深圳、广州、东莞、佛山、湛江、梅州、肇庆、惠州、南宁、柳州、江门、桂林、玉林、百色等两广区域。分销业务涵盖医院纯销、商业调拨、药品快批及终端配送等,拥有完善的全国商业网络和深度渗透的南区终端市场网络,拥有华南地区自动化程度最高、服务能力最强的专业医药物流中心,也是华南地区首家获批第三方医药物流资质的企业。目前,国药一致分销全力打造智慧型供应链新的分销商业模式,已在广州、梅州等地开设6家DTC专业药房,并进入B2B药品电子商务领域。
未来,国药一致将以内涵增长为主,由关注规模增长转变为质量效益领先;充分内部挖潜和资源整合;创新产品技术,创新商业模式,创新服务水平;积极发展新业务,坚持科工贸协同发展,成为具有国际竞争力的医药健康产品和服务提供商。
愿景:以世界优秀企业为标杆,做中国医药企业的典范;
使命:生命与健康的守护者;
地址:深圳市福田区八卦四路15号一致药业大厦
Brief introduction to China National Accord Medicines Corporation., Ltd
China National Accord Medicines Corporation., Ltd (short as Sinopharm Accord) is a comprehensive pharmaceutical publicly listed company (A Share: 000028, B Share: 200028) with four businesses—medicine distribution, pharmaceutical industry and pharmaceutical logistic. Our subordinate enterprises are distributed in Guangdong and Guangxi. Up to the end of 2007, the total asset of Sinopharm Accord amounts to 2,900,000,000 yuan and the annual sale exceeds 8,000,000,000 yuan.
The total employees in Sinopharm Accord reach 4,500. In 2004, the company transformed from Shenzhen state-owned enterprise into a member of China National Pharmaceutical Group Corporation. Sinopharm Accord promotes “Care for life, attend to health” as its enterprise concept and adheres to the Scientific development View as development by customer and market as orientation and organizational capability as its basis. With strategies of Strategic Drive and Integration Operation, Accordance Pharm brings along internal restructure, strategic adjustment, and alteration of marketing strategy. Deeper fine management has brought advance of three competitive edges “efficiency, variety and client” and improvement in three comprehensive abilities “operation, payoff and growth”.
In the management control mode of integrated operation of the company, functions of headquarter is exercised by the four centers--operation management, finance management, human resource and administrative management. Management functions are exercised by the four business divisions—distribution division, pharmaceutical division, chain store division, logistics division.
Sinopharm Holding Guangzhou Co., Ltd is the core enterprise of Distribution Division. With integrated operation, the division maximizes resource sharing such as verity, information, capital, logistic storage, and forms “Large Southern Region” platform of the medical & pharmaceutical business field in South China.
Shenzhen Zhijun Pharmaceutical Co., Ltd.is the core enterprise of Pharmaceutical Division, the subsidiary of China National Pharmaceutical Group Corporation. With the advantage of the scientific research cooperation with Sichuan Industrial Institute of Antibiotics, the division has extended product lines, and developed relevant corollary equipment for the production of crude drug. With construction of an integrative industrial chain, the division enters into new field under appropriate situation, and quickens its deploitation of international mainstream marketplace. Accordance Pharm strives to become one of the top 20 of Chinese pharmaceutical industry in five years.
Accordance Pharm Chain Store Co., Ltd is the large operation platform of Chain Store Division. Through connection with asset relationship, Accordance Pharm Chain Store will gradually shape itself into a pattern of unification between stock structure of chain type and management structure. The division aims to achieve a scale of 600 chain stores to reveal the brand influence of Accordance Drug Store and the power of terminal control in 2010.
With support of the national integrated logistics distribution network of Sinopharm Holding and regional logistics warehouse with perfect corollary equipment, Logistics Division is devoted to meeting the requirement that the client network distribution be multi-terminal and deep coverage in all regions, strives to provide the customers solution of integrative logistic distribution, and develops to be the third logistic company in the pharmaceutical circulation domain.
The prospective Accordance Pharm will continue to commit itself to the business restructuring and capital strategic operation and aims to become excellent public company in the China Medical and Pharmaceutical Industry and to become the first medical and pharmaceutical brand in South China.